Evidence map›Paper›PMID 27999793›Full record

ArticleBioMed research international2016

Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.

Jun-Hui Sun, Tanyang Zhou, Tongyin Zhu, Yuelin Zhang, Chunhui Nie, Jing Ai, Guanhui Zhou, Aibin Zhang, Meng-Jie Dong, Wei-Lin Wang and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Portal Vein Stenting Combined withBioMed research international · 2020
    Article
  7. Lobaplatin promotesCell death & disease · 2019
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jun-Hui SunDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.ORCID 0000-0003-1947-8330
Tanyang ZhouDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Tongyin ZhuDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Yuelin ZhangDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Chunhui NieDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Jing AiDepartment of Ophthalmology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China.
Guanhui ZhouDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Aibin ZhangDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Meng-Jie DongDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
Wei-Lin WangDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.
Shu-Sen ZhengDepartment of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China.ORCID 0000-0003-1459-8261
Zhejiang University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim was to assess the therapeutic value of portal vein stenting (PVS) combined with iodine-125 seed (

Indexed as

Carcinoma, HepatocellularCatheterizationLiver NeoplasmsStentsVenous ThrombosisAdultAgedAged, 80 and overChemoembolization, TherapeuticDisease-Free SurvivalFemaleFollow-Up StudiesHumansIodine RadioisotopesMaleMiddle AgedIodine Radioisotopes

Identifiers

PMID27999793
PMCPMC5143688
OpenAlexW2556751639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.